DailyStocks.com

Sign up   Log In
Lost Password?
MyDailyStocks
Set Home Page
What's New
Site Map
Help
FAQ
  
GLOSSARY STOCK ANALYSIS INSIDER BUYS PRODUCT REVIEWS EDUCATION SEARCH
Symbol:
Bookmark and Share

MARKET WATCH
DayTrading Portal
Free Stock Charts
Free Technical Analysis
REVIEWS
Online Brokers Review 2014
Investors Daily
Top 20 Baby Boomer WebSites
SEARCH ENGINES
Online Courses
Financial Advisers
SEC filings
Finance Jobs
Brand Reviews Only
Start-up Content Only

Wells Fargo (WFC) Continues to Boost Mortgage Business - Analyst Blog
Wells Fargo & Company (WFC) has taken yet another step to drive up mortgage originations.
Integra Poised on Impressive Duraseal Product Line, Solid Q2 - Analyst Blog
On Jul 3, 2014, we issued an updated research report on Integra LifeSciences Holdings Corporation (IART).
Consolidated Edison Grows Utility Business, Adds Solar - Analyst Blog
On Sep 15, we have issued an updated research report on Consolidated Edison, Inc. (ED).
Sanofi & MyoKardia Ink Deal to Develop Cardiomyopathies - Analyst Blog
Sanofi (SNY) announced that it has entered into an agreement with MyoKardia, Inc. to discover and develop targeted therapeutics for cardiomyopathies.
Cisco to Buy Metacloud to Develop Global Intercloud - Analyst Blog
Cisco (CSCO) expressed its intent to acquire Pasadena, CA-based, privately-held, Metacloud. Financial terms of the deal were not disclosed.
Viad Corp Buys Blitz to Boost Position in Audio Visual Market - Analyst Blog
Viad Corp. (VVI) has closed the acquisition of Blitz Communications Group Limited and its affiliates ("Blitz"), thereby expanding its Marketing and Events group.
ReneSola (SOL) to Supply SolarMax Inverters in Australia - Analyst Blog
ReneSola Ltd. (SOL) announced that it has inked a partnership agreement with SolarMax to supply the latter's solar inverters in Australia.
Bayer/Orion Progress with Prostate Cancer Drug ODM-201 - Analyst Blog
Bayer (BAYRY) and Orion Corp. announced that they have started enrolling patients for a phase III study on ODM-201.
OncoGenex's Phase III Prostate Cancer Study Fully Enrolled - Analyst Blog
OncoGenex Pharmaceuticals, Inc. (OGXI) has finished enrolling patients in a phase III study (AFFINITY) on custirsen for metastatic castrate-resistant prostate cancer.
ITT Extends Reliable, Low-Cost Connectors to Danish Railways - Analyst Blog
Shares of ITT Corp (ITT) gained 0.15% yesterday after the company announced the completion of a connector upgrade project with Danish Railways.


Content Library
News
Insider Buys and Activist Buys
RESEARCH
Stock Search Engine
Guide to Financial Sites
FAQ
Investors Research Portal
Glossary
Company Overviews
Forums
Work with DailyStocks
License our Glossary
Write for us
About us
Feedback
Partners & Sponsors
InvestingChannel
COPYRIGHT© 1997-2012 DailyStocks. All Rights Reserved. Privacy Policy.
Link to this page http://www.dailystocks.com/zacks_category.php, notify us and we will consider your web site to our directory